Manila Times Business
Cartesian Therapeutics Announces New Employment Inducement Grant
FREDERICK, Md., June 12, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of an inducement award to one new employee. On June 8, 2026, the Company issued to this employee an option to purchase an aggregate of 6,100 shares of the Company’s common stock with an exercise price of $5.86, the closing trading price of the Company’s common stock
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Ops+AI and Arrowhead Strategy Group Announce Strategic Partnership to Help Founders Build Smarter, Stronger, More Scalable Companies
Just now
ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical
Just now
HAMANASI ADVENTURE & DIVE RESORT, BELIZE RANKED #1 HOTEL IN CENTRAL AMERICA AND #15 IN THE WORLD IN 2026 TRIPADVISOR TRAVELERS’ CHOICE BEST OF THE BEST AWARDS
Just now
SpaceX stock soars in debut and makes Elon Musk the first trillionaire
Just now